176 A Randomized Controlled Trial of Rsv Prophylaxis with Motavizumab Vs Palivizumab in Young Children with Hemodynamically Significant Congenital Heart Disease

Timothy F. Feltes,Henry M. Sondheimer,Robert Tulloh,Brian Harris,Kathryn Jensen,Genevieve A Losonsky,P Griffin

176 A Randomized Controlled Trial of Rsv Prophylaxis with Motavizumab Vs Palivizumab in Young Children with Hemodynamically Significant Congenital Heart Disease

2010

Timothy F. Feltes
Henry M. Sondheimer
Robert Tulloh
Brian Harris
Kathryn Jensen
Genevieve A Losonsky
P Griffin

176 A Randomized Controlled Trial of Rsv Prophylaxis with Motavizumab Vs Palivizumab in Young Children with Hemodynamically Significant Congenital Heart Disease

Keywords:

Randomized controlled trial
Physical therapy
Motavizumab
Heart disease
Intensive care medicine
Medicine
Palivizumab
Pediatrics
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations